What Lee Pharma does

Lee Pharma Limited is a research-driven Indian pharmaceutical manufacturer founded in 1997 in Hyderabad by A. Venkata Reddy. The company operates across the pharmaceutical value chain, producing Active Pharmaceutical Ingredients (APIs), intermediate chemicals, pellets and granules (including modified-release, enteric-coated, and multiple-unit pellet systems), finished oral solid dosage formulations, and contract development and manufacturing (CDMO) services. Its portfolio spans more than 60 commercial APIs across therapeutic categories including antidiabetic, cardiovascular, antiulcerative, neurological, psychiatric, anti-infective, and specialty areas, with pipeline extensions into finished formulations such as DPP-4 inhibitor combinations and direct oral anticoagulants. The company holds multi-jurisdictional regulatory certifications — USFDA, EUGMP, WHO GMP, AFM Japan, and ISO 9001/14001 — across its API and finished formulation facilities located in Hyderabad and Visakhapatnam, enabling exports to 30+ countries.

Lee Pharma's business model is B2B enterprise sales of pharmaceutical inputs and services to generic pharmaceutical manufacturers and CDMO clients globally, with quote-based pricing negotiated on volume, regulatory filings, and product specifications. Revenue is generated across four streams: API sales, finished formulation sales, pellets/granules (semi-finished dosage forms), and CDMO services. The company extends into branded consumer health and nutraceuticals through a wholly-owned subsidiary, Lee Health Domain (I) Pvt Ltd, which markets products such as Meno-D (PCOS), Imunolact (immune support), Actokin (Boswellia extract), and Bio-Cartilage Smoothwalk Tablets (UAE-authorized). The company is founder-owned and controlled, with a five-person board covering technical, quality assurance, and business development functions, and holds granted US and European patents on Linezolid processes alongside multiple pending patent applications across Sitagliptin, Saxagliptin, Lurasidone, Montelukast, and novel chemical entities.

Name

Lee Pharma

Legal name

Lee Pharma Limited

Website

https://leepharma.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

251–500 employees

Short description

Lee Pharma Limited is a Hyderabad-based, founder-owned Indian pharmaceutical manufacturer founded in 1997, producing 60+ APIs, pellets, finished formulations, and CDMO services for generic pharma companies and partners across 30+ countries under USFDA, EUGMP, and WHO GMP certifications.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing (Active Pharmaceutical Ingredients)

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule API & Intermediates CDMO (HLAGABAA)

akta.pro secondary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Active pharmaceutical ingredients
• Generic drug formulations
• Pharmaceutical contract manufacturing
• Pharmaceutical pellets granules
• API contract development

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Active Pharmaceutical Ingredients (APIs): Lee Pharma manufactures and sells a comprehensive portfolio of Active Pharmaceutical Ingredients including cardiovascular, anti-diabetic, anti-ulcerative, anti-psychotic, anti-viral, anti-bacterial, and other therapeutic categories. Products are sold to pharmaceutical companies globally with various DMF statuses (USDMF, CEP filed, DMF available).
2. Finished Formulations: Manufacturing and sale of finished dosage forms including tablets, capsules, and oral solid dosages. Products are developed as generics against reference listed drugs and sold to pharmaceutical partners globally.
3. Contract Development and Manufacturing (CDMO): Lee Pharma provides contract development and manufacturing services for pharmaceutical companies, offering API synthesis, formulation development, and manufacturing capabilities for partners seeking outsourced production.
4. Pellets, Granules & Semi-finished Dosage Forms: Manufacturing and sale of intermediate pharmaceutical products including pellets, MUPs, and DC granules that serve as inputs for other pharmaceutical manufacturers producing finished tablets and capsules.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Lee Pharma manufactures and sells Active Pharmaceutical Ingredients (APIs) across cardiovascular, antidiabetic, antiulcerative, neurological, psychiatric, anti-infective, and specialty therapeutic categories, pharmaceutical pellets and granules (enteric coated, sustained release, MUPs, taste masked, DC granules), finished oral solid dosage formulations, and provides CDMO services for pharmaceutical partners seeking outsourced API synthesis, formulation development, and commercial manufacturing.

Product overview

Lee Pharma is a research-driven pharmaceutical company established in 1997, operating as a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs), pellets and granules, and finished formulations. The company's product portfolio includes over 60 commercial APIs spanning therapeutic areas such as antidiabetic, cardiovascular, antiulcerative, neurological, psychiatric, anti-infective, and specialty categories. Their CDMO services support contract development and manufacturing. The company also markets consumer health products including Meno-D for PCOS, Imunolact immune support supplements, and Actokin Boswellia extract. Manufacturing facilities are certified by USFDA, EUGMP, and WHO GMP.

Differentiator

Problem solved

Functional benefit

Brands

• Lee Health Domain: Subsidiary company focused on healthcare products and novel formulations

Products and services

• Active Pharmaceutical Ingredients (APIs)

Quantifiable outcome

• Serving pharmaceutical partners in 30+ countries globally
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Granules India: Granules India manufactures APIs, pellets, DC granules, and finished formulations with strong global regulatory approvals — the closest direct peer to Lee Pharma's integrated API + pellets + formulations model. Both serve global generic pharma customers with similar dosage-form technology platforms.
• Laurus Labs: Laurus Labs is an Indian API and CDMO manufacturer with USFDA/EU GMP facilities, offering API synthesis, formulation development, and contract manufacturing — directly comparable to Lee Pharma's CDMO and API business across therapeutic categories including cardiovascular and anti-infectives.
• Aarti Drugs: Aarti Drugs is an Indian API manufacturer with therapeutic categories spanning anti-diabetic, cardiovascular, anti-infective, and gastrointestinal — directly overlapping with Lee Pharma's API portfolio and serving similar global generic pharma customers.
• Suven Pharmaceuticals: Suven Pharmaceuticals focuses on API manufacturing and CDMO services for global pharma with CRAMS (Contract Research and Manufacturing) offerings — a close peer to Lee Pharma's CDMO segment with similar global customer base and therapeutic focus on CNS and specialty molecules.
• Shilpa Medicare: Shilpa Medicare manufactures APIs (including oncology) and finished formulations with USFDA/EU GMP approvals — comparable to Lee Pharma in regulatory certification profile and in offering both APIs and specialty formulations to global customers.
• SMS Pharmaceuticals: SMS Pharmaceuticals is an Indian API manufacturer with USFDA and EU GMP certifications producing APIs across anti-infective, cardiovascular, and CNS categories — directly comparable to Lee Pharma in API portfolio breadth and regulated market access.

Broad incumbents

• Divis Laboratories: Divis Laboratories is a leading Indian API and intermediates manufacturer with deep custom synthesis capabilities and USFDA/EU GMP facilities — a larger, established peer operating broadly in the same API space with comparable customer base of innovator and generic pharma.
• Aurobindo Pharma: Aurobindo Pharma is a vertically integrated Indian pharma major with large-scale API manufacturing, formulations, and global regulatory approvals across many of the same therapeutic categories as Lee Pharma — a broad incumbent competitor in both APIs and finished formulations.
• Piramal Pharma: Piramal Pharma operates a major CDMO business with global pharma innovator relationships and USFDA/EU GMP facilities — a larger incumbent in the contract manufacturing space where Lee Pharma competes for CDMO engagements.
• Dr. Reddy's Laboratories: Dr. Reddy's is a large Indian pharmaceutical company with significant API and finished formulation businesses, holding USFDA/EU GMP approvals and operating across cardiovascular, gastrointestinal, and anti-diabetic categories — a broad incumbent with overlapping therapeutic focus to Lee Pharma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/leepharma
• Facebookfacebook.com/P-Pharma-118919128653556
• LinkedInlinkedin.com/company/lee-pharma-ltd

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lee Pharma